Ability 0 7 0 7 O
to 8 10 8 10 O
swallow 11 18 11 18 O
and 19 22 19 22 O
retain 23 29 23 29 O
orally 30 36 30 36 O
- 36 37 36 37 O
administered 37 49 37 49 O
medication 50 60 50 60 B-treatment
and 61 64 61 64 O
does 65 69 65 69 O
not 70 73 70 73 O
have 74 78 74 78 O
any 79 82 79 82 O
clinically 83 93 83 93 O
significant 94 105 94 105 O
gastro 106 112 106 112 B-chronic_disease
- 112 113 112 113 I-chronic_disease
intestinal 113 123 113 123 I-chronic_disease
abnormalities 124 137 124 137 I-chronic_disease
( 138 139 138 139 O
e.g. 139 143 139 143 O
, 143 144 143 144 O
malabsorption 145 158 145 158 B-chronic_disease
syndrome 159 167 159 167 I-chronic_disease
or 168 170 168 170 O
major 171 176 171 176 O
resection 177 186 177 186 B-treatment
of 187 189 187 189 I-treatment
the 190 193 190 193 I-treatment
stomach 194 201 194 201 I-treatment
or 202 204 202 204 I-treatment
bowel 205 210 205 210 I-treatment
) 210 211 210 211 O

Absolute 0 8 212 220 B-clinical_variable
neutrophil 9 19 221 231 I-clinical_variable
count 20 25 232 237 I-clinical_variable
> 26 27 238 239 O
= 27 28 239 240 O
1,500 29 34 241 246 B-lower_bound
/ 34 35 246 247 I-lower_bound
mcL 35 38 247 250 I-lower_bound

Alanine 0 7 251 258 B-clinical_variable
aminotransferase 8 24 259 275 I-clinical_variable
( 25 26 276 277 I-clinical_variable
ALT 26 29 277 280 I-clinical_variable
) 29 30 280 281 I-clinical_variable
( 31 32 282 283 I-clinical_variable
serum 32 37 283 288 I-clinical_variable
glutamate 38 47 289 298 I-clinical_variable
pyruvate 48 56 299 307 I-clinical_variable
transaminase 57 69 308 320 I-clinical_variable
[ 70 71 321 322 I-clinical_variable
SGPT 71 75 322 326 I-clinical_variable
] 75 76 326 327 I-clinical_variable
) 76 77 327 328 I-clinical_variable
= 78 79 329 330 O
< 79 80 330 331 O
2.5 81 84 332 335 B-upper_bound
x 85 86 336 337 I-upper_bound
institutional 87 100 338 351 I-upper_bound
upper 101 106 352 357 I-upper_bound
limit 107 112 358 363 I-upper_bound
of 113 115 364 366 I-upper_bound
normal 116 122 367 373 I-upper_bound

Aspartate 0 9 374 383 B-clinical_variable
aminotransferase 10 26 384 400 I-clinical_variable
( 27 28 401 402 I-clinical_variable
AST 28 31 402 405 I-clinical_variable
) 31 32 405 406 I-clinical_variable
( 33 34 407 408 O
serum 34 39 408 413 B-clinical_variable
glutamic 40 48 414 422 I-clinical_variable
oxaloacetic 49 60 423 434 I-clinical_variable
transaminase 61 73 435 447 I-clinical_variable
[ 74 75 448 449 I-clinical_variable
SGOT 75 79 449 453 I-clinical_variable
] 79 80 453 454 I-clinical_variable
) 80 81 454 455 O
= 82 83 456 457 O
< 83 84 457 458 O
2.5 85 88 459 462 B-upper_bound
x 89 90 463 464 I-upper_bound
institutional 91 104 465 478 I-upper_bound
upper 105 110 479 484 I-upper_bound
limit 111 116 485 490 I-upper_bound
of 117 119 491 493 I-upper_bound
normal 120 126 494 500 I-upper_bound

Creatinine 0 10 501 511 B-clinical_variable
clearance 11 20 512 521 I-clinical_variable
> 21 22 522 523 O
= 22 23 523 524 O
60 24 26 525 527 B-lower_bound
mL 27 29 528 530 I-lower_bound
/ 29 30 530 531 I-lower_bound
min/1.73 30 38 531 539 I-lower_bound
m^2 39 42 540 543 I-lower_bound
for 43 46 544 547 O
patients 47 55 548 556 O
with 56 60 557 561 O
creatinine 61 71 562 572 O
levels 72 78 573 579 O
above 79 84 580 585 O
institutional 85 98 586 599 O
normal 99 105 600 606 O

Eastern 0 7 607 614 B-clinical_variable
Cooperative 8 19 615 626 I-clinical_variable
Oncology 20 28 627 635 I-clinical_variable
Group 29 34 636 641 I-clinical_variable
( 35 36 642 643 I-clinical_variable
ECOG 36 40 643 647 I-clinical_variable
) 40 41 647 648 I-clinical_variable
performance 42 53 649 660 I-clinical_variable
status 54 60 661 667 I-clinical_variable
< 61 62 668 669 O
2 63 64 670 671 B-upper_bound

Hemoglobin 0 10 672 682 B-clinical_variable
> 11 12 683 684 O
= 12 13 684 685 O
9 14 15 686 687 B-lower_bound
g 16 17 688 689 I-lower_bound
/ 17 18 689 690 I-lower_bound
dL 18 20 690 692 I-lower_bound
without 21 28 693 700 O
transfusion 29 40 701 712 O
within 41 47 713 719 O
7 48 49 720 721 B-upper_bound
days 50 54 722 726 I-upper_bound
prior 55 60 727 732 I-upper_bound
to 61 63 733 735 O
enrollment 64 74 736 746 O

Leukocytes 0 10 747 757 B-clinical_variable
> 11 12 758 759 O
= 12 13 759 760 O
3,000 14 19 761 766 B-lower_bound
/ 19 20 766 767 I-lower_bound
mcL 20 23 767 770 I-lower_bound

Life 0 4 771 775 B-clinical_variable
expectancy 5 15 776 786 I-clinical_variable
of 16 18 787 789 O
greater 19 26 790 797 O
than 27 31 798 802 O
12 32 34 803 805 B-lower_bound
months 35 41 806 812 I-lower_bound

Platelets 0 9 813 822 B-clinical_variable
> 10 11 823 824 O
= 11 12 824 825 O
100,000 13 20 826 833 B-lower_bound
/ 20 21 833 834 I-lower_bound
mcL 21 24 834 837 I-lower_bound

The 0 3 838 841 O
effects 4 11 842 849 O
of 12 14 850 852 O
methoxyamine 15 27 853 865 B-treatment
( 28 29 866 867 I-treatment
TRC102 29 35 867 873 I-treatment
) 35 36 873 874 I-treatment
on 37 39 875 877 O
the 40 43 878 881 O
developing 44 54 882 892 O
human 55 60 893 898 O
fetus 61 66 899 904 O
are 67 70 905 908 O
unknown 71 78 909 916 O

have 0 4 917 921 O
pathologic 5 15 922 932 O
diagnosis 16 25 933 942 O
of 26 28 943 945 O
adenocarcinoma 29 43 946 960 B-cancer
or 44 46 961 963 O
large 47 52 964 969 B-cancer
cell 53 57 970 974 I-cancer
carcinoma 58 67 975 984 I-cancer
of 68 70 985 987 I-cancer
the 71 74 988 991 I-cancer
lung 75 79 992 996 I-cancer
with 80 84 997 1001 O
confirmation 85 97 1002 1014 O
by 98 100 1015 1017 O
immunohistochemistry 101 121 1018 1038 O
( 122 123 1039 1040 O
e.g. 123 127 1040 1044 O
, 127 128 1044 1045 O
transcription 129 142 1046 1059 O
termination 143 154 1060 1071 O
factor 155 161 1072 1078 O
1 162 163 1079 1080 O
[ 164 165 1081 1082 O
TTF-1 165 170 1082 1087 O
] 170 171 1087 1088 O
positivity 172 182 1089 1099 O
) 182 183 1099 1100 O
( 184 185 1101 1102 O
histologic 185 195 1102 1112 O
tissue 196 202 1113 1119 O
diagnosis 203 212 1120 1129 O
is 213 215 1130 1132 O
recommended 216 227 1133 1144 O
, 227 228 1144 1145 O
but 229 232 1146 1149 O
cytology 233 241 1150 1158 O
is 242 244 1159 1161 O
acceptable 245 255 1162 1172 O
) 255 256 1172 1173 O

